Advertisement
Screener

INMED PHARMACEUTICALS INC. (INM) Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

1.8 / 5 stars · 22/62 Roast Me

INMED PHARMACEUTICALS INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value

INMED PHARMACEUTICALS INC. (INM) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value of $1.85 per share for the 12-month period ending 2023-06-30, per its 10-K filed 2023-09-29.

Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure

us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue · last filed 2023-09-29

  • INMED PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2023 was $1.85, a 94.59% decline from fiscal 2022.
  • INMED PHARMACEUTICALS INC. share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value for fiscal 2022 was $34.20.
Period endShare-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value 12 month
2023-06-30$1.85
10-K · filed 2023-09-29
2022-06-30$34.20
10-K · filed 2023-09-29

Similar stocks

Stock NameCountryMarket CapPE Ratio
Apimeds Pharmaceuticals US, Inc. (APUS)United States$0.008B
Ensysce Biosciences, Inc. (ENSC)United States$0.008B-0.37
CNS Pharmaceuticals, Inc. (CNSP)United States$0.007B
EXICURE, INC. (XCUR)United States$0.008B-1.54
Acurx Pharmaceuticals, Inc. (ACXP)United States$0.007B-0.97
SOLIGENIX, INC. (SNGX)United States$0.008B
Imunon, Inc. (IMNN)United States$0.008B-0.56
SYNLOGIC, INC. (SYBX)United States$0.007B
Bolt Biotherapeutics, Inc. (BOLT)United States$0.007B-0.26
Enveric Biosciences, Inc. (ENVB)United States$0.007B-0.63